Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

256 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size.
Bevan JS, Atkin SL, Atkinson AB, Bouloux PM, Hanna F, Harris PE, James RA, McConnell M, Roberts GA, Scanlon MF, Stewart PM, Teasdale E, Turner HE, Wass JA, Wardlaw JM. Bevan JS, et al. Among authors: james ra. J Clin Endocrinol Metab. 2002 Oct;87(10):4554-63. doi: 10.1210/jc.2001-012012. J Clin Endocrinol Metab. 2002. PMID: 12364434 Clinical Trial.
The future of somatostatin analogue therapy.
Stewart PM, James RA. Stewart PM, et al. Among authors: james ra. Baillieres Best Pract Res Clin Endocrinol Metab. 1999 Oct;13(3):409-18. doi: 10.1053/beem.1999.0031. Baillieres Best Pract Res Clin Endocrinol Metab. 1999. PMID: 10909432 Review.
Continuous infusion of octreotide in acromegaly.
James RA, Chatterjee S, White MC, Hall K, Moller N, Kendall-Taylor P. James RA, et al. Lancet. 1989 Nov 4;2(8671):1083-7. doi: 10.1016/s0140-6736(89)91092-1. Lancet. 1989. PMID: 2572807
256 results